Viewing Study NCT07273760


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2025-12-26 @ 12:26 AM
Study NCT ID: NCT07273760
Status: COMPLETED
Last Update Posted: 2025-12-10
First Post: 2025-11-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation
Sponsor: AryoGen Pharmed Co.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module